Education Symposia from the 18th European Stroke Conference Stockholm, 26th May, 2009 |
|||||||||||||
| Teaching course 1 | Difficult decision-making in stroke management | ||||||||||||
| J. de Keyser | Thrombolysis decisions in particular clinical situations | ||||||||||||
| D. Werring | Botulinum toxin for spasticity after stroke: when to treat? | ||||||||||||
| E. Jüttler | Individual decision making in malignant MCA infarction and hemicraniectomy | ||||||||||||
| V. Murray | Antidepressive therapy after stroke: when is it indicated? | ||||||||||||
| Teaching course 2 | Stroke Mimics | ||||||||||||
| P.D. Lyden | Differential diagnoses of TIA and stroke | ||||||||||||
| H. Mattle | Uncommon TIA/stroke-mimics (HANDLE, posterior reversible encephalopathy) | ||||||||||||
| A. Carson | Functional paralysis | ||||||||||||
| Teaching course 3 | Heart and brain | ||||||||||||
| A. Chamorro | Difficult decision making in patients with AF-associated stroke | ||||||||||||
| J. Jensen | Raised troponin-levels in acute stroke: what does it mean? | ||||||||||||
| E. Touzé | Should we look for coronary heart disease in stroke patients? | ||||||||||||
| A. Slowik | Stroke and heart failure | ||||||||||||
| Teaching course 4 | Stroke recurrence | ||||||||||||
| B. Carlberg | BP lowering after stroke: when to start, what to start, how much? | ||||||||||||
| K. Asplund | How do we make persons change life-style after stroke? | ||||||||||||
| Teaching course 5 | Translational basic science in stroke | ||||||||||||
| V. Berezowski | Novel in vitro models of the Neurovascular Unit | ||||||||||||
| T. Wieloch | Mild hypothermia – neuroprotection that works | ||||||||||||
| Teaching course 6 | Stroke in young adults | ||||||||||||
| T. Brandt | Dissection | ||||||||||||
| J-L. Mas | PFO-Update | ||||||||||||
| R. Salman | Arterio-venous malformations | ||||||||||||
| Teaching course 7 | Stroke and vision | ||||||||||||
| N. Bornstein | The retinal vessels as mirror of the brain vessels | ||||||||||||
| A. Kesler | Episodic loss of vision: diagnostic challenges | ||||||||||||
| D. Kömpf | Oculomotor disturbances | ||||||||||||
| Teaching course 8 | Primary prevention of stroke and vascular cognitive impairment | ||||||||||||
| H-C. Diener | Primary stroke prevention: principles and players | ||||||||||||
| P. Wester | The metabolic syndrome and diabetes as precursors of stroke | ||||||||||||
| P.J. Touboul | Screening for atherosclerosis as surrogate risk factors for stroke | ||||||||||||
| V. Hachinski | Vascular cognitive impairment and dementia: can it be prevented? | ||||||||||||
| Teaching course 9 | Stroke syndromes | ||||||||||||
| R. Kern | Borderzone ischemia syndromes: hemodynamics, embolism, or both? | ||||||||||||
| E. Carrera | Posterior cerebral artery syndromes | ||||||||||||
| M. Zuber | Cerebral vasoconstriction syndromes | ||||||||||||
| E. Carrera | Cerebellar stroke syndromes | ||||||||||||
| Teaching course 10 | Stroke in the very old | ||||||||||||
| A. Lindgren | Stroke in the very old: epidemiological and clinical overview | ||||||||||||
| G. Ford | Pharmacological aspects of stroke prevention in the elderly patient | ||||||||||||
| O. Benavente | Stroke prevention in elderly patients with atrial fibrillation | ||||||||||||
| A. Förster | Management of thrombolysis in elderly patients | ||||||||||||